NO20041840L - Rosuvastatin ved predemente tilstander - Google Patents

Rosuvastatin ved predemente tilstander

Info

Publication number
NO20041840L
NO20041840L NO20041840A NO20041840A NO20041840L NO 20041840 L NO20041840 L NO 20041840L NO 20041840 A NO20041840 A NO 20041840A NO 20041840 A NO20041840 A NO 20041840A NO 20041840 L NO20041840 L NO 20041840L
Authority
NO
Norway
Prior art keywords
predement
rosuvastatin
conditions
predement conditions
Prior art date
Application number
NO20041840A
Other languages
English (en)
Norwegian (no)
Inventor
Timothy Martin Piser
Hans Basun
Thor Rak
Original Assignee
Astrazeneca Ab Global Ip
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip
Publication of NO20041840L publication Critical patent/NO20041840L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
NO20041840A 2001-10-19 2004-05-05 Rosuvastatin ved predemente tilstander NO20041840L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0103509A SE0103509D0 (sv) 2001-10-19 2001-10-19 Rosuvastatin in pre demented states
PCT/SE2002/001911 WO2003032995A1 (en) 2001-10-19 2002-10-18 Rosuvastatin in pre demented states

Publications (1)

Publication Number Publication Date
NO20041840L true NO20041840L (no) 2004-05-05

Family

ID=20285721

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041840A NO20041840L (no) 2001-10-19 2004-05-05 Rosuvastatin ved predemente tilstander

Country Status (19)

Country Link
US (1) US20060229321A1 (es)
EP (1) EP1446123A1 (es)
JP (1) JP2005505605A (es)
KR (1) KR20040058201A (es)
CN (1) CN1604780A (es)
AR (1) AR036891A1 (es)
BR (1) BR0213434A (es)
CA (1) CA2463597A1 (es)
CO (1) CO5580773A2 (es)
HU (1) HUP0401798A3 (es)
IL (1) IL161380A0 (es)
IS (1) IS7218A (es)
MX (1) MXPA04003631A (es)
NO (1) NO20041840L (es)
PL (1) PL369573A1 (es)
RU (1) RU2004112422A (es)
SE (1) SE0103509D0 (es)
WO (1) WO2003032995A1 (es)
ZA (1) ZA200402844B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2657076A1 (en) 2003-08-28 2005-03-17 Teva Pharmaceutical Industries Ltd. Process for the preparation of rosuvastatin calcium
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
US7777034B2 (en) 2003-11-24 2010-08-17 Teva Pharmaceutical Industries Ltd. Crystalline ammonium salts of rosuvastatin
ES2364143T3 (es) 2003-12-02 2011-08-25 Teva Pharmaceutical Industries Ltd. Estandar de referencia para caracterización de rosuvastatina.
CA2573857A1 (en) 2004-07-13 2006-02-16 Teva Pharmaceutical Industries Ltd. A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step
TWI345562B (en) 2005-02-22 2011-07-21 Teva Pharma Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
MX2007004427A (es) 2005-08-16 2007-06-14 Teva Pharma Intermedio de rosuvastatina cristalina.
WO2012073256A1 (en) 2010-11-29 2012-06-07 Cadila Healthcare Limited Salts of rosuvastatin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
US7189703B2 (en) * 1998-01-09 2007-03-13 Intracell, Llc Treatment and diagnosis of alzheimer's disease
AR022462A1 (es) * 1999-02-06 2002-09-04 Astrazeneca Uk Ltd Uso de un agente que disminuye el colesterol
US20030100493A1 (en) * 2001-07-19 2003-05-29 Sol Weiss Sublingual use of inhibitors in the biosynthesis of cholesterol

Also Published As

Publication number Publication date
AR036891A1 (es) 2004-10-13
EP1446123A1 (en) 2004-08-18
BR0213434A (pt) 2004-11-09
HUP0401798A3 (en) 2005-06-28
SE0103509D0 (sv) 2001-10-19
ZA200402844B (en) 2005-01-24
MXPA04003631A (es) 2004-07-30
US20060229321A1 (en) 2006-10-12
RU2004112422A (ru) 2005-04-10
IS7218A (is) 2004-04-13
KR20040058201A (ko) 2004-07-03
IL161380A0 (en) 2004-09-27
CA2463597A1 (en) 2003-04-24
JP2005505605A (ja) 2005-02-24
CN1604780A (zh) 2005-04-06
WO2003032995A8 (en) 2004-06-03
CO5580773A2 (es) 2005-11-30
HUP0401798A2 (hu) 2005-01-28
PL369573A1 (en) 2005-05-02
WO2003032995A1 (en) 2003-04-24

Similar Documents

Publication Publication Date Title
DK1303496T3 (da) Pyrimidinderivater
DE50204184D1 (de) Espressobrüheinrichtung
NO20042742L (no) Pyrimidinforbindelser
DE50103741D1 (de) Welle-Nabe-Verbindung
ATE335486T1 (de) Hydrazono-malonitrile
DE50204551D1 (de) Kugelgelenk
DE50203412D1 (de) Schwenkkolbenverdränger
ATE355059T1 (de) Isoxazolopyridinone
NO20032291D0 (no) Pyrimidinderivater
DE50201862D1 (de) Messwandler
NO20041840L (no) Rosuvastatin ved predemente tilstander
DE50203093D1 (de) Losradlager
ATE319694T1 (de) Phenylalkyne
ATA18372001A (de) Gelenksbolzenbaueinheit
DE50202088D1 (de) Garmodulsystem
FI20012004A (fi) Kaapelointimenetelmä
FR2827943B3 (fr) Profile en c
ATA13992002A (de) Schlackengranulierungsanlage
DE50108381D1 (de) Synchronisierschaltungsanordnung
ATE345337T1 (de) Delta1 -pyrroline
AT500276B8 (de) Radschwenksystem
DE10142202B8 (de) Hochvakuumbedampfungsanlage
DE10196706D2 (de) Nagelfeile
ATA6162001A (de) Schneekette
FI5027U1 (fi) Yläpohjarakenne

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application